NASDAQ:SSKN Strata Skin Sciences (SSKN) Stock Price, News & Analysis $0.14 +0.01 (+7.46%) As of 01:15 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Strata Skin Sciences Stock (NASDAQ:SSKN) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Strata Skin Sciences alerts:Sign Up Key Stats Today's Range$0.12▼$0.1550-Day Range$0.12▼$0.2952-Week Range$0.11▼$3.86Volume74,817 shsAverage Volume269,912 shsMarket Capitalization$822.55 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Strata Skin Sciences, Inc. is a medical technology company headquartered in Edison, New Jersey, that specializes in developing and commercializing dermatological devices and therapies. The company’s flagship offering is the XTRAC® excimer laser system, an FDA‐cleared, 308-nanometer ultraviolet light device used to treat skin conditions such as vitiligo and psoriasis. Strata’s product suite also includes associated accessories and disposables, as well as clinical services and training programs designed to support dermatology practices and improve patient outcomes. Strata Skin Sciences expanded its portfolio and market presence through the strategic acquisition of PhotoMedex in 2019, bringing together complementary phototherapy and energy-based technologies under one roof. This integration enabled the company to widen its geographic footprint, serving physicians and clinics across the United States and through select international distribution partners in Europe and Asia. Strata continues to invest in clinical research, product enhancements and next-generation platforms aimed at addressing a range of dermatologic disorders with noninvasive treatment modalities. Under the leadership of Chairman and Chief Executive Officer David J. Peskin, Strata Skin Sciences maintains a direct sales force of clinical specialists who provide installation, training and ongoing support for its laser and light‐based systems. The company’s operational strategy focuses on fostering long-term partnerships with dermatology practices, promoting the adoption of its technologies through peer-reviewed publications, educational initiatives and real-world evidence studies. As a result, Strata has positioned itself as a focused provider of advanced phototherapy solutions within the skin disease market.AI Generated. May Contain Errors. Read More Strata Skin Sciences Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks3rd Percentile Overall ScoreSSKN MarketRank™: Strata Skin Sciences scored higher than 3% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.5 / 5Analyst RatingSell Consensus RatingStrata Skin Sciences has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageStrata Skin Sciences has received no research coverage in the past 90 days.Read more about Strata Skin Sciences' stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Strata Skin Sciences are expected to grow in the coming year, from ($1.05) to ($1.04) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Strata Skin Sciences is -0.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Strata Skin Sciences is -0.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioStrata Skin Sciences has a P/B Ratio of 0.11. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Strata Skin Sciences' valuation and earnings. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for SSKN. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldStrata Skin Sciences does not currently pay a dividend.Dividend GrowthStrata Skin Sciences does not have a long track record of dividend growth. News and Social Media0.6 / 5News SentimentN/A Search Interest2 people have searched for SSKN on MarketBeat in the last 30 days. Company Ownership1.1 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Strata Skin Sciences insiders have not sold or bought any company stock.Percentage Held by Insiders40.92% of the stock of Strata Skin Sciences is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions32.43% of the stock of Strata Skin Sciences is held by institutions.Read more about Strata Skin Sciences' insider trading history. Receive SSKN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Strata Skin Sciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SSKN Stock News HeadlinesNew Peer-Reviewed Publication Confirms Unprecedented Response Rates for STRATA's Excimer Laser Combined with JAK Inhibitors in Pediatric VitiligoMay 18, 2026 | globenewswire.comSTRATA Skin Sciences Confirms Nasdaq DelistingFebruary 19, 2026 | globenewswire.com$30 stock to buy before Starlink goes public (WATCH NOW!)A little-known stock pick with money-doubling potential over the next year is revealed for free in the first three minutes of a new video. This company is a critical piece of Elon Musk's fast-growing Starlink technology. It could climb 100 percent or more over the next year as Elon brings Starlink public in what may be the biggest IPO in history. No credit card is required to get the ticker.May 29 at 1:00 AM | Paradigm Press (Ad)STRATA cites study supporting 308 nm laser for psoriasisFebruary 18, 2026 | msn.comJohns Hopkins Dermatology Expands Advanced Care for Inflammatory and Autoimmune Skin Conditions with Addition of XTRAC® Excimer LaserFebruary 18, 2026 | globenewswire.comSTRATA Skin Sciences Highlights Meta-Analysis Confirming Clinical Efficacy of 308 nm Excimer Laser for Plaque PsoriasisFebruary 17, 2026 | globenewswire.comSTRATA Skin Sciences stock plunges after Nasdaq delisting noticeFebruary 12, 2026 | in.investing.comStrata Skin Sciences to Delist and Go DarkFebruary 11, 2026 | tipranks.comSee More Headlines SSKN Stock Analysis - Frequently Asked Questions How have SSKN shares performed this year? Strata Skin Sciences' stock was trading at $1.26 on January 1st, 2026. Since then, SSKN shares have decreased by 89.7% and is now trading at $0.13. How were Strata Skin Sciences' earnings last quarter? Strata Skin Sciences, Inc. (NASDAQ:SSKN) posted its earnings results on Thursday, November, 13th. The medical device company reported ($0.36) EPS for the quarter, missing the consensus estimate of ($0.24) by $0.12. The medical device company earned $6.93 million during the quarter, compared to analysts' expectations of $7.72 million. Strata Skin Sciences had a negative net margin of 35.64% and a negative trailing twelve-month return on equity of 476.73%. Read the conference call transcript. When did Strata Skin Sciences' stock split? Strata Skin Sciences's stock reverse split on the morning of Friday, June 7th 2024.The 1-10 reverse split was announced on Friday, June 7th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, June 7th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. How do I buy shares of Strata Skin Sciences? Shares of SSKN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Strata Skin Sciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that Strata Skin Sciences investors own include Amarin (AMRN), AbbVie (ABBV), OPKO Health (OPK), AT&T (T), Agile Therapeutics (AGRX), Advanced Micro Devices (AMD) and Avino Silver & Gold Mines (ASM). Company Calendar Last Earnings11/13/2025Today5/29/2026Next Earnings (Estimated)5/29/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (3m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 SSKN's financial health is in the Red zone, according to TradeSmith. SSKN has been in this zone for over 3 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MEDICAL INFO SYS Sub-IndustryMedical Equipment Current SymbolNASDAQ:SSKN CIK1051514 Webwww.strataskinsciences.com Phone(215) 619-3200Fax215-619-3208Employees120Year Founded1989Profitability EPS (Trailing Twelve Months)($1.41) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$10.09 million Net Margins-35.64% Pretax Margin-36.34% Return on Equity-476.73% Return on Assets-33.49% Debt Debt-to-Equity Ratio10.22 Current Ratio0.95 Quick Ratio0.75 Sales & Book Value Annual Sales$30.98 million Price / Sales0.03 Cash FlowN/A Price / Cash FlowN/A Book Value$1.19 per share Price / Book0.12Miscellaneous Outstanding Shares5,888,000Free Float3,479,000Market Cap$822.55 thousand OptionableNot Optionable Beta-0.05 Social Links A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for June 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.Get This Free Report This page (NASDAQ:SSKN) was last updated on 5/29/2026 by MarketBeat.com Staff. From Our PartnersThe 1934 playbookIn 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...American Alternative | SponsoredSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX just filed. The clock is ticking.Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...The Oxford Club | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Strata Skin Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Strata Skin Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
